Pachyonychia congenita: a case report.

Authors

  • Mónica Lorena Cárdenas
  • Luis Fernando Balcázar
  • Natalia Vargas

Keywords:

pachyonychia congenita, cytokeratins, nails malformed

Abstract

Pachyonychia congenita is a rare genodermatoses, caused by mutations of keratins genes K6a, K16 (PC type I) and K6b, K17 (PC type 2). We report the case of an 8 year old patient, with congenital pachyonychia of the 20 nails, leukokeratosis oris and the absence of steatocystomas. Based on the clinical findings and the family history we considered the diagnosis of PC type 1.

Author Biographies

Mónica Lorena Cárdenas

Residente I año de Dermatología. Universidad del Valle

Luis Fernando Balcázar

Dermatólogo docente. Escuela de Dermatología de la Universidad del Valle.

Natalia Vargas

Residente III año de Dermatología. Universidad del Valle.

References

1. Kaspar R. Challenges in developing therapies for rare diseases including pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10:62-6.
2. Leacman S, Kaspar R. Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10:3-17.
3. Leachman S, Hickerson R, Hull P, Smith F, Milstone L. Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci. 2008;51:151-7.
4. Judge MR, Mclean WH, Munro CS. Disorders of keratinization. En: Burns T, Breathnach S, Cox N, Griffiths C, editores. Rook´s textbook of dermatology. 7th edition. Mashachusetts: Blackwell Publishing; 2004. p. 34.89-34.91.
5. Liao H, Sayers J, Wilson N, Irvine A, Mellerio J. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenital. J Dermatol Sci. 2007;48:199-205.
6. Milstone L, Fleckman P, Leachman S, Leigh I. Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005;10:18-20.
7. Swartling C, Vahlquis A. Treatment of pachyonychia congenita with plantar injections of botulinum toxin. Br. J.Dermatol. 2006;154:763-5.
8. Hickerson RP, Leake D, Pho LN, Leachman SA, Kaspar RL. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. J Dermatol Sci. 2009;56:82-8.

How to Cite

1.
Cárdenas ML, Balcázar LF, Vargas N. Pachyonychia congenita: a case report. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 13 [cited 2024 Jul. 5];17(4):242-4. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/181

Downloads

Download data is not yet available.

Published

2019-02-13

How to Cite

1.
Cárdenas ML, Balcázar LF, Vargas N. Pachyonychia congenita: a case report. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 13 [cited 2024 Jul. 5];17(4):242-4. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/181
QR Code
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views